Vitamins in COVID-19 severe or critically - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Zhang, 2020 0.50 [0.17; 1.50]
0.50 [0.17 ; 1.50 ] Zhang, 2020 1 0% 56 NA not evaluable deathsdetailed results Cao, 2020 0.15 [0.01; 3.29]
COVID-VIT-D, 2022 1.48 [0.75; 2.92]
Jamali Moghadam Siahkali, 2021 1.00 [0.19; 5.40]
Kumari, 2020 0.60 [0.22; 1.64]
Zhang, 2020 0.50 [0.17; 1.50]
0.84 [0.47 ; 1.49 ] Cao, 2020, COVID-VIT-D, 2022, Jamali Moghadam Siahkali, 2021, Kumari, 2020, Zhang, 2020 5 21% 850 moderate not evaluable deaths (time to event analysis only)detailed results Zhang, 2020 0.50 [0.17; 1.50]
0.50 [0.17 ; 1.50 ] Zhang, 2020 1 0% 56 NA not evaluable clinical deteriorationdetailed results Cao, 2020 0.11 [0.01; 2.21]
Zhang, 2020 0.87 [0.23; 3.27]
0.49 [0.08 ; 3.03 ] Cao, 2020, Zhang, 2020 2 35% 97 moderate not evaluable clinical improvementdetailed results Cao, 2020 1.67 [0.84; 3.33]
1.67 [0.84 ; 3.33 ] Cao, 2020 1 0% 42 NA not evaluable clinical improvement (14-day)detailed results Cao, 2020 2.00 [0.58; 6.94]
2.00 [0.58 ; 6.94 ] Cao, 2020 1 0% 41 NA not evaluable clinical improvement (21-day)detailed results Cao, 2020 1.50 [0.22; 10.08]
1.50 [0.22 ; 10.08 ] Cao, 2020 1 0% 41 NA not evaluable clinical improvement (7-day)detailed results Cao, 2020 2.38 [0.38; 14.70]
2.38 [0.38 ; 14.70 ] Cao, 2020 1 0% 41 NA not evaluable clinical improvement (time to event analysis only)detailed results Cao, 2020 1.67 [0.84; 3.33]
1.67 [0.84 ; 3.33 ] Cao, 2020 1 0% 42 NA not evaluable mechanical ventilationdetailed results Jamali Moghadam Siahkali, 2021 1.30 [0.31; 5.40]
Kumari, 2020 0.76 [0.33; 1.76]
0.87 [0.42 ; 1.80 ] Jamali Moghadam Siahkali, 2021, Kumari, 2020 2 0% 210 low not evaluable radiologic improvement (14-day)detailed results Cao, 2020 5.54 [1.01; 30.50]
5.54 [1.01 ; 30.50 ] Cao, 2020 1 0% 41 NA not evaluable serious adverse eventsdetailed results Cao, 2020 0.11 [0.01; 2.21]
0.11 [0.01 ; 2.21 ] Cao, 2020 1 0% 41 NA not evaluable adverse eventsdetailed results Cao, 2020 1.60 [0.38; 6.81]
1.60 [0.38 ; 6.81 ] Cao, 2020 1 0% 41 NA not evaluable 0.0 10.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-09 03:15 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 91
- treatments: 1244,523,885,734,1439
- roots T: 290
